https://www.selleckchem.com/products/icrt14.html
ratio [OR], 1.16; 95% confidence interval [CI], 0.83-1.61; P = .396). Intraoperative HES administration was not associated with postoperative renal outcomes (AKI OR, 0.97; 95% CI, 0.81-1.16; P = .723; CKD stage 3a or higher or all-cause mortality hazard ratio, 1.01; 95% CI, 0.89-1.14; P = .92. Subgroup analysis yielded similar results. Conclusions Intraoperative 6% HES 130/0.4 administration was not significantly associated with short- and long-term renal function or renal survival up to 5 years in patients undergoing partial or radica
Curtir
Comentario
Compartilhar
